Exon Therapeutics INFINITY

INFINITY SIROLIMUS-ELUTING CORONARY STENT SYSTEM

The INFINITY Sirolimus-Eluting Coronary Stent System is a state-of-the-art device used in interventional cardiology to treat coronary artery disease (CAD). It features a fully biodegradable, biocompatible polymer (PLGA) with a precise sirolimus loading density of 1.2 ± 0.2 µg/mm and a uniform 6 µm coating. The stent is designed for consistent drug release, promoting optimal neointimal coverage and reducing the risk of In-Stent Restenosis (ISR) and late thrombosis. Mounted on a hydrophilic-coated PTCA catheter, the system ensures safe and effective stent deployment.

Technical Specification

Parameter
Available stent lengths
Available stent diameters
Stent Material
Stent Design
Stent Platform
Stent foreshortening
Stent Recoil
Stent struct thickness
Drug
Coating Thickness
Specification
10, 13, 15, 18, 20, 24, 28, 32, 36, 40, 44 & 48mm
2.25, 2.50, 2.75, 3.00, 3.50 & 4.00mm
L605 Cobalt-Chromium (Co-cr) alloy
Open and closed hybrid cell design
Cobal + C
<2%
<4%
63µm
Sirolimus
6µm
Parameter
Delivery System Type
Polymer Type
Nominal Pressure
Rated Burst Pressure
Guidewire Compatibility
Guiding Catheter Compatibility
Specification
Monorail rapid exchange
Biodegradable polymer
8 Bar
16 Bar
0.014”
5F

Let's Connect